(L) Loews - Overview
Stock: Insurance, Hotels, Pipelines, Plastics
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.27% |
| Yield on Cost 5y | 0.56% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 91.0% |
| Payout Ratio | 3.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 14.8% |
| Relative Tail Risk | 3.90% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.98 |
| Alpha | 12.50 |
| Character TTM | |
|---|---|
| Beta | 0.528 |
| Beta Downside | 0.609 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.51% |
| CAGR/Max DD | 1.47 |
Description: L Loews December 19, 2025
Loews Corporation (NYSE:L) operates as a diversified holding company with four primary business lines: multi-line commercial property-and-casualty insurance, natural-gas transportation and storage, a boutique hotel chain, and the manufacture of extrusion-blown and injection-molded plastic containers and resins. The insurance segment sells specialty coverages-including professional liability, cyber, and loss-sensitive programs-to professional firms, healthcare providers, and mid-size enterprises, primarily through independent agents and brokers.
In 2023 the insurance unit generated roughly $6.2 billion of revenue, posting a combined ratio of 94%-a modest improvement over the 96% ratio recorded in 2022, indicating tighter underwriting discipline. The energy segment, driven by Boardwalk Pipeline Partners, saw an 8% year-over-year increase in transported natural-gas volumes, benefitting from sustained demand for LNG and ethane in the Gulf Coast. Meanwhile, Loews Hotels reported a 12% rise in RevPAR (revenue per available room) as travel demand rebounded, supporting the hospitality contribution to overall earnings.
For a deeper, data-driven view of Loews’ valuation and scenario analysis, the ValueRay platform provides a concise, decision-ready overview.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 1.45b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.59 > 1.0 |
| NWC/Revenue: 64.43% < 20% (prev 88.12%; Δ -23.69% < -1%) |
| CFO/TA 0.04 > 3% & CFO 3.79b > Net Income 1.45b |
| Net Debt (8.88b) to EBITDA (2.36b): 3.75 < 3 |
| Current Ratio: 3.19 > 1.5 & < 3 |
| Outstanding Shares: last quarter (209.4m) vs 12m ago -4.81% < -2% |
| Gross Margin: 44.07% > 18% (prev 0.58%; Δ 4349 % > 0.5%) |
| Asset Turnover: 21.21% > 50% (prev 20.28%; Δ 0.93% > 0%) |
| Interest Coverage Ratio: 0.65 > 6 (EBITDA TTM 2.36b / Interest Expense TTM 434.0m) |
Altman Z'' 1.84
| A: 0.13 (Total Current Assets 16.89b - Total Current Liabilities 5.30b) / Total Assets 85.94b |
| B: 0.21 (Retained Earnings 17.69b / Total Assets 85.94b) |
| C: 0.00 (EBIT TTM 284.1m / Avg Total Assets 84.78b) |
| D: 0.25 (Book Value of Equity 16.53b / Total Liabilities 66.72b) |
| Altman-Z'' Score: 1.84 = BBB |
Beneish M -2.71
| DSRI: 1.02 (Receivables 10.94b/10.14b, Revenue 17.98b/16.96b) |
| GMI: 1.31 (GM 44.07% / 57.90%) |
| AQI: 1.00 (AQ_t 0.68 / AQ_t-1 0.68) |
| SGI: 1.06 (Revenue 17.98b / 16.96b) |
| TATA: -0.03 (NI 1.45b - CFO 3.79b) / TA 85.94b) |
| Beneish M-Score: -2.71 (Cap -4..+1) = A |
What is the price of L shares?
Over the past week, the price has changed by +3.64%, over one month by -0.58%, over three months by +6.13% and over the past year by +22.83%.
Is L a buy, sell or hold?
What are the forecasts/targets for the L price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 60 | -43.2% |
| Analysts Target Price | 60 | -43.2% |
| ValueRay Target Price | 127 | 20.3% |
L Fundamental Data Overview January 31, 2026
P/S = 1.1857
P/B = 1.1827
P/EG = 2.69
Revenue TTM = 17.98b USD
EBIT TTM = 284.1m USD
EBITDA TTM = 2.36b USD
Long Term Debt = 8.44b USD (from longTermDebt, last quarter)
Short Term Debt = 1.00b USD (from shortTermDebt, last quarter)
Debt = 9.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 8.88b USD (from netDebt column, last quarter)
Enterprise Value = 23.88b USD (21.66b + Debt 9.44b - CCE 7.22b)
Interest Coverage Ratio = 0.65 (Ebit TTM 284.1m / Interest Expense TTM 434.0m)
EV/FCF = 7.25x (Enterprise Value 23.88b / FCF TTM 3.29b)
FCF Yield = 13.80% (FCF TTM 3.29b / Enterprise Value 23.88b)
FCF Margin = 18.32% (FCF TTM 3.29b / Revenue TTM 17.98b)
Net Margin = 8.07% (Net Income TTM 1.45b / Revenue TTM 17.98b)
Gross Margin = 44.07% ((Revenue TTM 17.98b - Cost of Revenue TTM 10.06b) / Revenue TTM)
Gross Margin QoQ = 45.36% (prev 42.91%)
Tobins Q-Ratio = 0.28 (Enterprise Value 23.88b / Total Assets 85.94b)
Interest Expense / Debt = 1.19% (Interest Expense 112.0m / Debt 9.44b)
Taxrate = 22.21% (153.0m / 689.0m)
NOPAT = 221.0m (EBIT 284.1m * (1 - 22.21%))
Current Ratio = 3.19 (Total Current Assets 16.89b / Total Current Liabilities 5.30b)
Debt / Equity = 0.52 (Debt 9.44b / totalStockholderEquity, last quarter 18.29b)
Debt / EBITDA = 3.75 (Net Debt 8.88b / EBITDA 2.36b)
Debt / FCF = 2.69 (Net Debt 8.88b / FCF TTM 3.29b)
Total Stockholder Equity = 17.52b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.71% (Net Income 1.45b / Total Assets 85.94b)
RoE = 8.29% (Net Income TTM 1.45b / Total Stockholder Equity 17.52b)
RoCE = 1.09% (EBIT 284.1m / Capital Employed (Equity 17.52b + L.T.Debt 8.44b))
RoIC = 0.83% (NOPAT 221.0m / Invested Capital 26.59b)
WACC = 5.75% (E(21.66b)/V(31.10b) * Re(7.86%) + D(9.44b)/V(31.10b) * Rd(1.19%) * (1-Tc(0.22)))
Discount Rate = 7.86% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.51%
[DCF Debug] Terminal Value 87.35% ; FCFF base≈2.73b ; Y1≈3.04b ; Y5≈4.00b
Fair Price DCF = 528.2 (EV 118.03b - Net Debt 8.88b = Equity 109.15b / Shares 206.7m; r=5.90% [WACC]; 5y FCF grow 13.28% → 2.90% )
EPS Correlation: -2.53 | EPS CAGR: -44.79% | SUE: 0.0 | # QB: 0
Revenue Correlation: 96.31 | Revenue CAGR: 7.00% | SUE: 3.34 | # QB: 1